BlackRock’s SAB Biotherapeutics SABS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.3K | Sell |
|
|||||
|
2025
Q1 | $30.3K | Sell |
|
|||||
|
2024
Q4 | $85.8K | Buy |
|
|||||
|
2024
Q3 | $59.8K | Buy |
|
|||||
|
2024
Q2 | $42.6K | Buy |
|
|||||
|
2024
Q1 | $28.8K | Buy |
|
|||||
|
2023
Q4 | $36.2K | Hold |
|
|||||
|
2023
Q3 | $33.2K | Hold |
|
|||||
|
2023
Q2 | $43.7K | Sell |
|
|||||
|
2023
Q1 | $48.4K | Buy |
|
|||||
|
2022
Q4 | $63.8K | Sell |
|
|||||
|
2022
Q3 | $88K | Sell |
|
|||||
|
2022
Q2 | $185K | Buy |
|
|||||
|
2022
Q1 | $273K | Buy |
|
|||||
|
2021
Q4 | $559K | Buy |
|